Back
Aehr Test Systems 10K Form
Buy
65
AEHR
Aehr Test Systems
Last Price:
$13.85
Seasonality Move:
25.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-10 | 10Q | AEHR/Aehr Test Systems Quarterly |
2024-01-12 | 10Q | AEHR/Aehr Test Systems Quarterly |
2023-10-12 | 10Q | AEHR/Aehr Test Systems Quarterly |
2023-04-13 | 10Q | AEHR/Aehr Test Systems Quarterly |
2023-01-13 | 10Q | AEHR/Aehr Test Systems Quarterly |
2022-10-14 | 10Q | AEHR/Aehr Test Systems Quarterly |
Receive AEHR News And Ratings
See the #1 stock for the next 7 days that we like better than AEHR
AEHR Financial Statistics
Sales & Book Value
Annual Sales: | $59M |
---|---|
Cash Flow: | $-5.1M |
Price / Cash Flow: | 444.54 |
Annual Sales: | $4.11 |
Price / Book: | 3.43 |
Profitability
EPS (TTM): | -0.13000 |
---|---|
Net Income (TTM): | $-3.9M |
Gross Margin: | $23.9M |
Return on Equity: | -3.24% |
Return on Assets: | -2.75% |
Aehr Test Systems Earnings Forecast
Key Aehr Test Systems Financial Ratios
-
The Gross Profit Margin over the past 29 years for AEHR is 40.59%.
-
The Selling, General & Administrative Expenses for AEHR have been equal to 31.00% of Gross Profit Margin.
-
The Research & Development expenses have been 17.74% of Revenue.
-
The Net Earning history of AEHR is -6.63% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 18 years.
Aehr Test Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Semiconductors & Semiconductor Equipment |
Sector: | Information Technology |
Current Symbol: | AEHR |
CUSIP: | 00760J |
Website: | aehr.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.68 |
Quick Ratio: | 2.48 |
Price-to-Earnings
Trailing P/E Ratio: | 13.54 |
---|---|
Forward P/E Ratio: | 38.84 |
AEHR Technical Analysis vs Fundamental Analysis
Buy
65
Aehr Test Systems (AEHR)
is a Buy
Is Aehr Test Systems a Buy or a Sell?
-
Aehr Test Systems stock is rated a BuyThe current Aehr Test Systems [AEHR] share price is $14.11. The Score for AEHR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.